Lite Strategy

Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

حول Lite Strategy

التأسيس

2018

المجتمع

Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.

تفاصيل جمع التبرعات

جولة التمويلالمبلغتقييم
التاريخ
المستثمرين
Post-IPO
﷼‎375.00M
--
2025-07-21
--